1997
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas D, Yarbough P, Vlahov D, Tsarev S, Nelson K, Saah A, Purcell R. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal Of Clinical Microbiology 1997, 35: 1244-1247. PMID: 9114415, PMCID: PMC232737, DOI: 10.1128/jcm.35.5.1244-1247.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersHistory of hepatitisVirus antibodiesBlood donorsHigh-risk drug-using practicesHomosexual menHepatitis E virus antibodiesHepatitis E diseaseC virus antibodyHepatitis C antibodyHigh-risk groupHigh-risk populationHigh-risk sexual practicesDrug use practicesHepatitis AE virusC antibodySubclinical infectionB antibodiesE diseaseDrug usersEnzyme immunoassaySerum samplesHomosexual malesInfection
1995
Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Nelson K, Vlahov D, Solomon L, Cohn S, Muñoz A. Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md. JAMA Internal Medicine 1995, 155: 1305-1311. PMID: 7778962, DOI: 10.1001/archinte.1995.00430120091011.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionHuman immunodeficiency virusDrug usersVirus infectionImmunodeficiency virusEffective human immunodeficiency virus (HIV) vaccineHuman immunodeficiency virus risk factorsIncident human immunodeficiency virus (HIV) infectionsHuman immunodeficiency virus (HIV) seroconversionHuman immunodeficiency virus (HIV) antibodyHuman immunodeficiency virus (HIV) vaccinesIllicit drug injectionInjecting Drug UsersHigh-risk populationImmunodeficiency virus vaccinesIncidence of infectionPrevention of infectionSterile injection equipmentEnzyme-linked immunosorbent assaySeronegative participantsStudy clinicAnnual incidenceImmunodeficiency syndromeOverall incidence